Ureteral stent-associated complications-where we are and where we are going

Nature Reviews Urology

Volumn 12, Issue 1, 2015, Pages 17-25

  Lange, Dirk ^a   Bidnur, Samir ^a   Hoag, Nathan ^a   Chew, Ben H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADABLE STENT; CLINICAL STUDY; COMPRESSION; DRUG ELUTING STENT; HUMAN; PRIORITY JOURNAL; REVIEW; SELF EXPANDABLE METALLIC STENT; STENT COMPLICATION; STENT DISCOMFORT; STENT ENCRUSTATION; STENT MIGRATION; TISSUE ENGINEERED STENT; URETER STENT; URETERAL APERISTALSIS; URINARY TRACT INFECTION; ADVERSE EFFECTS; BIODEGRADABLE IMPLANT; DEVICES; FOREIGN BODY; PROCEDURES; PROSTHESIS; PROSTHESIS FAILURE; STENT; URETER;

BIOMATERIAL;

ABSORBABLE IMPLANTS; BIOCOMPATIBLE MATERIALS; FOREIGN-BODY MIGRATION; HUMANS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; STENTS; URETER;

EID: 84926179351     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2014.340     Document Type: Review

References (78)

1. Finney, R. P. Experience with new double J ureteral catheter stent. J. Urol. 120, 678-681 (1978)
2. Joshi, H. B. et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J. Urol. 169, 1060-1064 (2003)
3. Giannarini, G. et al. Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire. BJU Int. 107, 648-654 (2011)
4. Al-Kandari, A. M. et al. Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. J. Endourol. 21, 698-702 (2007)
5. Chew, B. H. et al. Pilot study of ureteral movement in stented patients: first step in understanding dynamic ureteral anatomy to improve stent comfort. J. Endourol. 21, 1069-1075 (2007)
6. Ramsay, J. W. et al. The effects of double J stenting on unobstructed ureters. An experimental and clinical study. Br. J. Urol. 57, 630-634 (1985)
7. Venkatesh, R. et al. Impact of a double-pigtail stent on ureteral peristalsis in the porcine model: initial studies using a novel implantable magnetic sensor. J. Endourol. 19, 170-176 (2005)
8. Kinn, A. C. & Lykkeskov-Andersen, H. Impact on ureteral peristalsis in a stented ureter. An experimental study in the pig. Urol. Res. 30, 213-218 (2002)
9. Dunn, C. J., Matheson, A. & Faulds, D. M. Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs Aging 19, 135-161 (2002)
10. Davenport, K., Timoney, A. G. & Keeley, F. X. A comparative in vitro study to determine the beneficial effect of calcium-channel and 1-adrenoceptor antagonism on human ureteric activity. BJU Int. 98, 651-655 (2006)
11. Rajpathy, J. et al. An in vitro study on human ureteric smooth muscle with the 1-adrenoceptor subtype blocker, tamsulosin. BJU Int. 102, 1743-1745 (2008)
12. Damiano, R. et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J. Endourol. 22, 651-656 (2008)
13. Wang, C. J., Huang, S. W. & Chang, C. H. Effects of specific-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urol. Res. 37, 147-152 (2009)
14. Beddingfield, R. et al. Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J. Urol. 181, 170-176 (2009)
15. Deliveliotis, C. et al. Is there a role for 1-blockers in treating double-J stent-related symptoms? Urology 67, 35-39 (2006)
16. Damiano, R. et al. Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur. Urol. 48, 673-678 (2005)
17. Erturk, E., Sessions, A. & Joseph, J. V. Impact of ureteral stent diameter on symptoms and tolerability. J. Endourol. 17, 59-62 (2003)
18. Pryor, J., Carey, P. & Lippert, M. Migration of silicone ureteral catheters. J. Endourol. 2, 283-286 (1988)
19. Jeon, S. S., Choi, Y. S. & Hong, J. H. Determination of ideal stent length for endourologic surgery. J. Endourol. 21, 906-910 (2007)
20. el-Faqih, S. R. et al. Polyurethane internal ureteral stents in treatment of stone patients: morbidity related to indwelling times. J. Urol. 146, 1487-1491 (1991)
21. Nagele, U., Praetorius, M., Schilling, D., Stenzl, A. & Anastasiadis, A. G. Comparison of flexible grasping forceps and stone basket for removal of retracted ureteral stents. J. Endourol. 20, 418-422 (2006)
22. Livadas, K. E. et al. Ureteroscopic removal of mildly migrated stents using local anesthesia only. J. Urol. 178, 1998-2001 (2007)
23. LeRoy, A. J., Williams, H. J. Jr, Segura, J. W., Patterson, D. E. & Benson, R. C. Jr. Indwelling ureteral stents: percutaneous management of complications. Radiology 158, 219-222 (1986)
24. Kehinde, E. O. et al. Bacteriology of urinary tract infection associated with indwelling J ureteral stents. J. Endourol. 18, 891-896 (2004)
25. Reid, G., Denstedt, J. D., Kang, Y. S., Lam, D. & Nause, C. Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J. Urol. 148, 1592-1594 (1992)
26. Schierholz, J. M., Beuth, J. & Pulverer, G. Silver coating of medical devices for catheter-associated infections? Am. J. Med. 107, 101-102 (1999)
27. Tieszer, C., Reid, G. & Denstedt, J. Conditioning film deposition on ureteral stents after implantation. J. Urol. 160, 876-881 (1998)
28. Elwood, C. N. et al. Understanding urinary conditioning film components on ureteral stents: profiling protein components and evaluating their role in bacterial colonization. Biofouling 29, 1115-1122 (2013)
29. Shaw, G. L., Choong, S. K. & Fry, C. Encrustation of biomaterials in the urinary tract. Urol. Res. 33, 17-22 (2005)
30. Klis, R., Korczak-Kozakiewicz, E., Denys, A., Sosnowski, M. & Rozanski, W. Relationship between urinary tract infection and self-retaining double-J catheter colonization. J. Endourol. 23, 1015-1019 (2009)
31. Kehinde, E. O. et al. Factors predisposing to urinary tract infection after J ureteral stent insertion. J. Urol. 167, 1334-1337 (2002)
32. Farsi, H. M., Mosli, H. A., Al-Zemaity, M. F., Bahnassy, A. A. & Alvarez, M. Bacteriuria and colonization of double-pigtail ureteral stents: long-term experience with 237 patients. J. Endourol. 9, 469-472 (1995)
33. Singh, I. et al. Severely encrusted polyurethane ureteral stents: management and analysis of potential risk factors. Urology 58, 526-531 (2001)
34. Tunney, M. M., Keane, P. F., Jones, D. S. & Gorman, S. P. Comparative assessment of ureteral stent biomaterial encrustation. Biomaterials 17, 1541-1546 (1996)
35. Gorman, S. P. & Tunney, M. M. Assessment of encrustation behaviour on urinary tract biomaterials. J. Biomater. Appl. 12, 136-166 (1997)
36. Tunney, M. M., Keane, P. F. & Gorman, S. P. Assessment of urinary tract biomaterial encrustation using a modified Robbins device continuous flow model. J. Biomed. Mater. Res. 38, 87-93 (1997)
37. Rouprêt, M. et al. Can ureteral stent encrustation analysis predict urinary stone composition? Urology 66, 246-251 (2005)
38. Canales, B. K. et al. Presence of five conditioning film proteins are highly associated with early stent encrustation. J. Endourol. 23, 1437-1442 (2009)
39. Olweny, E. O. et al. Evaluation of the use of a biodegradable ureteral stent after retrograde endopyelotomy in a porcine model. J. Urol. 167, 2198-2202 (2002)
40. Lam, J. S. & Gupta, M. Tips and tricks for the management of retained ureteral stents. J. Endourol. 16, 733-741 (2002)
41. Acosta-Miranda, A. M., Milner, J. & Turk, T. M. The FECal Double-J: a simplified approach in the management of encrusted and retained ureteral stents. J. Endourol. 23, 409-415 (2009)
42. Borboroglu, P. G. & Kane, C. J. Current management of severely encrusted ureteral stents with a large associated stone burden. J. Urol. 164, 648-650 (2000)
43. Ather, M. H., Talati, J. & Biyabani, R. Physician responsibility for removal of implants: the case for a computerized program for tracking overdue double-J stents. Tech. Urol. 6, 189-192 (2000)
44. Borin, J. F., Melamud, O. & Clayman, R. V. Initial experience with full-length metal stent to relieve malignant ureteral obstruction. J. Endourol. 20, 300-304 (2006)
45. Kadlec, A. O., Ellimoottil, C. S., Greco, K. A. & Turk, T. M. Five-year experience with metallic stents for chronic ureteral obstruction. J. Urol. 190, 937-941 (2013)
46. Agrawal, S., Brown, C. T., Bellamy, E. A. & Kulkarni, R. The thermo-expandable metallic ureteric stent: an 11-year follow-up. BJU Int. 103, 372-376 (2009)
47. Liatsikos, E. N. et al. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment. J. Urol. 182, 2613-2617 (2009)
48. Barbalias, G. A. et al. Metal stents: a new treatment of malignant ureteral obstruction. J. Urol. 158, 54-58 (1997)
49. Wakui, M., Takeuchi, S., Isioka, J., Iwabuchi, K. & Morimoto, S. Metallic stents for malignant and benign ureteric obstruction. BJU Int. 85, 227-232 (2000)
50. Hendlin, K., Korman, E. & Monga, M. New metallic ureteral stents: improved tensile strength and resistance to extrinsic compression. J. Endourol. 26, 271-274 (2012)
51. Sountoulides, P., Kaplan, A., Kaufmann, O. G. & Sofikitis, N. Current status of metal stents for managing malignant ureteric obstruction. BJU Int. 105, 1066-1072 (2010)
52. Kukreja, N., Onuma, Y., Daemen, J. & Serruys, P. W. The future of drug-eluting stents. Pharmacol. Res. 57, 171-180 (2008)
53. Kallidonis, P. S., Georgiopoulos, I. S., Kyriazis, I. D., Al-Aown, A. M. & Liatsikos, E. N. Drug-eluting metallic stents in urology. Indian J. Urol. 30, 8-12 (2014)
54. Krambeck, A. E. et al. A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J. Urol. 183, 1037-1042 (2010)
55. Mendez-Probst, C. E. et al. The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospective randomized trial. BJU Int. 110, 749-754 (2012)
56. Kotsar, A. et al. Preclinical evaluation of new indomethacin-eluting biodegradable urethral stent. J. Endourol. 26, 387-392 (2012)
57. Liatsikos, E. N. et al. Application of paclitaxel-eluting metal mesh stents within the pig ureter: an experimental study. Eur. Urol. 51, 217-223 (2007)
58. Kallidonis, P. et al. Evaluation of zotarolimus-eluting metal stent in animal ureters. J. Endourol. 25, 1661-1667 (2011)
59. Al-Aown, A. et al. Ureteral stents: new ideas, new designs. Ther. Adv. Urol. 2, 85-92 (2010)
60. Venkatesan, N., Shroff, S., Jayachandran, K. & Doble, M. Polymers as ureteral stents. J. Endourol. 24, 191-198 (2010)
61. Chew, B. H. et al. Next generation biodegradable ureteral stent in a yucatan pig model. J. Urol. 183, 765-771 (2010)
62. Lingeman, J. E., Schulsinger, D. A. & Kuo, R. L. Phase I trial of a temporary ureteral drainage stent. J. Endourol. 17, 169-171 (2003)
63. Schlick, R. W. & Planz, K. Potentially useful materials for biodegradable ureteric stents. Br. J. Urol. 80, 908-910 (1997)
64. Schlick, R. W. & Planz, K. In vitro results with special plastics for biodegradable endoureteral stents. J. Endourol. 12, 451-455 (1998)
65. Lumiaho, J. et al. New bioabsorbable polylactide ureteral stent in the treatment of ureteral lesions: an experimental study. J. Endourol. 13, 107-112 (1999)
66. Lumiaho, J. et al. Drainage and antireflux characteristics of a biodegradable self-reinforced, self-expanding X-ray-positive poly-l,d-lactide spiral partial ureteral stent: an experimental study. J. Endourol. 21, 1559-1564 (2007)
67. Lumiaho, J. et al. The morphological, in situ effects of a self-reinforced bioabsorbable polylactide (SR-PLA 96) ureteric stent; an experimental study. J. Urol. 164, 1360-1363 (2000)
68. Li, G. et al. Introduction to biodegradable polylactic acid ureteral stent application for treatment of ureteral war injury. BJU Int. 108, 901-906 (2011)
69. Talja, M., Multanen, M., Välimaa, T. & Törmälä, P. Bioabsorbable SR-PLGA horn stent after antegrade endopyelotomy: a case report. J. Endourol. 16, 299-302 (2002)
70. Lumiaho, J., Heino, A., Aaltomaa, S., Välimaa, T. & Talja, M. A short biodegradable helical spiral ureteric stent provides better antireflux and drainage properties than a double-J stent. Scand. J. Urol. Nephrol. 45, 129-133 (2011)
71. Lingeman, J. E. et al. Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial. J. Urol. 169, 1682-1688 (2003)
72. Hadaschik, B. A. et al. Investigation of a novel degradable ureteral stent in a porcine model. J. Urol. 180, 1161-1166 (2008)
73. Liatsikos, E. et al. Ureteral obstruction: is the full metallic double-pigtail stent the way to go? Eur. Urol. 57, 480-486 (2010)
74. Tsuji, T. et al. Biodegradable stents as a platform to drug loading. Int. J. Cardiovasc. Intervent. 5, 13-16 (2003)
75. Kotsar, A. et al. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study. BJU Int. 103, 626-629 (2009)
76. Amiel, G. E., Yoo, J. J., Kim, B. S. & Atala, A. Tissue engineered stents created from chondrocytes. J. Urol. 165, 2091-2095 (2001)
77. Nakayama, Y., Zhou, Y. M. & Ishibashi-Ueda, H. Development of in vivo tissue-engineered autologous tissue-covered stents (biocovered stents). J. Artif. Organs 10, 171-176 (2007)
78. Erbel, R. et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 369, 1869-1875 (2007).